SCHEMBL29956480

SCHEMBL29956480

O=Cc1cccc2ncccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
MAPT P10636 3/20 0.58
KMT2A Q03164 5/20 0.56
ERN1 O75460 4/20 0.56
MEN1 O00255 4/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
HSP90AA1 P07900 2/20 0.56
NPC1 O15118 1/20 0.56
IDO1 P14902 1/20 0.56
RAB9A P51151 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TRIM24 O15164 1/20 0.52
TRIM33 Q9UPN9 1/20 0.52
POLB P06746 1/20 0.49
CYP3A4 P08684 1/20 0.47
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1071836 1.00 KDM4E (0.58) KDM4EMAPTKMT2AERN1MEN1
Hydrochloric Acid SCHEMBL27515294 0.98 KDM4E (0.56) KDM4EMAPTKMT2AERN1MEN1
SCHEMBL27761309 0.98 KDM4E (0.56) KDM4EMAPTKMT2AERN1MEN1
Hydrochloric Acid SCHEMBL27593107 0.98 KDM4E (0.56) KDM4EMAPTKMT2AERN1MEN1
SCHEMBL29935774 0.86 MAPT (0.56) KDM4EMAPTKMT2AERN1MEN1
SCHEMBL333756 0.86 MAPT (0.56) KDM4EMAPTKMT2AERN1MEN1
Hydrochloric Acid SCHEMBL27545773 0.84 MAPT (0.54) KDM4EMAPTKMT2AERN1MEN1
Hydrochloric Acid SCHEMBL27593140 0.84 MAPT (0.54) KDM4EMAPTKMT2AERN1MEN1
Quinoline SCHEMBL27947930 0.84 ALDH1A1 (0.57) KDM4EMAPTKMT2AERN1MEN1
Formamide SCHEMBL9731154 0.80 MAPT (0.48) KDM4EMAPTKMT2AERN1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
EP-4117663-A1 CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF 3+2 Pharma LLC (US) 2023-01-18 EP disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP KDM4E 2437/4885MAPT 2516/4885KMT2A 1069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.